Biopharma plant for Canada

Dutch chemicals company DSM NV will invest EUR 7 million in a new biopharmaceutical plant in Canada. The plant, to be located in Montreal , will have a capacity of 60,000 litres and will be used for the production of a new generation of drugs such as monoclonal antibodies and recombinant proteins.




For more projects, subscribe to our Project Preview Newsletter

Previous articleLukoil to build oil terminal in Leningrad region
Next articleRaccortubi: changes at the top
Stainless Steel World is part of The KCI Media Group, a group of companies focused on building and sustaining global communities in the flow control industries. We publish news on a daily basis and connect business-to-business professionals through our online communities, publications, conferences and exhibitions.